IP Library Granted Patent US 8,765,950
Granted Patent B2
US 8,765,950 · App. 13/346,178 · Granted Jul 1, 2014

Reagents for biomolecular labeling, detection and quantification employing raman spectroscopy

Inventors: Vincent Jo Davisson (West Lafavette, IN); Shirshendu K. Deb (Bansdroni Kolkata, IN); Giselle Marcelline Knudsen-Mooney (Indianapolis, IN); Meiguo Xin (West Lafayette, IN)
Assignee: Purdue Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,765,950
App. No.
13/346,178
Granted
Jul 1, 2014
Kind
B2
Abstract

The present disclosure provides isotopically substituted compounds of the formula (II): wherein T, U, V, W, X, Y, Z, R 0 , R 3 , R 4 , R 5 and R 6 are as defined in the detailed description. The method for detection and quantification using the same is also disclosed.

Claims (35)

1. A compound of formula (II):

where R 0 is either X or of the formula (IIa):

where Q, S, T, U, V, W, X, Y, and Z are each independently hydrogen, deuterium, halogen, substituted or unsubstituted C 1-20 alkyl, substituted or unsubstituted C 2-8 alkenyl, substituted or unsubstituted C 2-8 alkynyl, where at least one of Q, S, T, U, V, W, X, Y, and Z is deuterium,

where R 1 is substituted or unsubstituted C 2-8 alkynyl, —R′N 3 , —R′COOH, —R′C(O)OR″, —R′C(O)NH 2 , —R′NCS, —R′NCO, —R′NH 2 , —R′SH, —R′NC(O)CH 2 I, or —R′C(O)O-succinimide,

where R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are each independently hydrogen, halogen, substituted or unsubstituted C 1-20 alkyl, substituted or unsubstituted C 2-8 alkenyl, substituted or unsubstituted C 2-8 alkynyl, substituted or unsubstituted C 6-10 aryl, substituted or unsubstituted 5- to 10-membered heteroaryl, or substituted or unsubstituted 3- to 10-membered heterocyclyl,

where R 2 and R 3 , R 4 and R 5 , R 6 and R 7 , or R 8 and R 9 may, together with the atoms to which they are attached, form a substituted or unsubstituted 3- to 10- membered ring, and

where R′ and R″ are each independently selected from the group consisting of substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted C 2-8 alkenyl, substituted or unsubstituted C 2-8 alkynyl, substituted or unsubstituted C 6-10 aryl, substituted or unsubstituted 5- to 10-membered heteroaryl, and substituted or unsubstituted 3- to 10-membered heterocyclyl.

2. The compound of claim 1 , where one R 0 is of formula (IIa), and R 1 is —(CH 2 ) n N 3 , —(CH 2 ) n NH 2 , —(CH 2 ) n COOH, —(CH 2 ) n C(O)OR″, —(CH 2 ) n C(O)NH 2 , —(CH 2 ) n NCS, —(CH 2 ) n NCO, —(CH 2 ) n NH 2 , —(CH 2 ) n SH, —(CH 2 ) n NC(O)CH 2 I, —(CH 2 ) n C(O)O-succinimide, —(CH 2 ) n C≡CH, —(CH 2 ) n Ar 1 NCS, —(CH 2 ) n Ar 1 NH 2 , —(CH 2 ) n NC(O)CH 2 C≡CH, or —(CH 2 ) n C(O)NCH 2 CH 2 SH, and

where n is 1-10, and Ar 1 is substituted or unsubstituted C 6-10 aryl, substituted or unsubstituted 5- to 10-membered heteroaryl, or substituted or unsubstituted 3- to 10-membered heterocyclyl.

3. The compound of claim 1 , where the at least one of R 0 is of the formula (IIb):

4. The compound of claim 1 , where the at least one of R 0 is of the formula (IIc):

5. A compound of the formula (IId):

6. The compound of claim 1 , wherein the deuterated compound is obtained from a deuterated precursor.

7. The compound of claim 1 , wherein the deuterated compound is obtained by isotopic exchange of aromatic protons between an organic dye and a deuterated acidic media.

8. A method for evaluating a sample comprising the steps of: labeling at least a portion of an analyte with the compound of claim 1 , and detecting the labeled portion, wherein the analyte is selected from the group consisting of proteins, nucleic acids, lipids, and structural mimetic thereof, fragments thereof, or metabolites thereof.

9. The method of claim 8 , further comprising a step of:

labeling at least a portion of the analyte with a non-isotopic compound,

where the non-isotopic compound has the same chemical structure as the compound in claim 8 , and only differs in non-isotopic substitution.

10. The method of claim 8 , further comprising a step of:

separating the analyte from the sample.

11. The method of claim 8 , further comprising a step of:

applying particles onto the analyte.

12. The method of claim 8 , further comprising a step of:

applying the analyte onto a substrate.

13. The method of claim 10 , wherein the separating is selected from the group consisting of sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), two-demensional SDS-PAGE (2DGE), and western blot.

14. The method of claim 11 , wherein the particles comprise a metallic material.

15. The method of claim 14 , wherein the metal material is copper, silver, or gold.

16. The method of claim 12 , wherein the substrate comprises a semi-permeable or a permeable surface.

17. The method of claim 16 , wherein the substrate is selected from the group consisting of polymeric membranes, polymeric gels, and polymeric beads.

18. The method of claim 17 , wherein the substrate is nitrocellulose, polyvinylidene fluoride (PVDF), or polysulfone.

19. The method of claim 18 , wherein the analyte is specific xenobiotic chemicals derived from cells, bodily fluids, or tissues.

20. The method of claim 8 , wherein the analyte is pharmaceuticals, or environmental samples.

21. A method of multiplex analysis, comprising:

labeling a plurality of analytes with at least two compounds of claim 1 , and

detecting the labeled analytes.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 13, 2012
From: PURDUE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028364/0095 →
Continuity (3)
Division 12345071 · Dec 29, 2008
Provisional Application 61016836 · Dec 27, 2007
Related Publication 20120107830A1 · May 3, 2012